AU4152193A - Anti-DCC gene product specific monoclonal antibody - Google Patents
Anti-DCC gene product specific monoclonal antibodyInfo
- Publication number
- AU4152193A AU4152193A AU41521/93A AU4152193A AU4152193A AU 4152193 A AU4152193 A AU 4152193A AU 41521/93 A AU41521/93 A AU 41521/93A AU 4152193 A AU4152193 A AU 4152193A AU 4152193 A AU4152193 A AU 4152193A
- Authority
- AU
- Australia
- Prior art keywords
- monoclonal antibody
- dcc
- dcc gene
- gene product
- specific monoclonal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Abstract
This invention relates to monoclonal antibodies capable of specifically reacting with a peptide encoded by tumor suppressor gene DCC gene and to hybridomas capable of producing such monoclonal antibodies. In particular, the invention relates to mouse monoclonal antibody KM890 belonging to the IgG3 subclass, which is specifically reactive with a DCC gene DCC-2, and to a hybridoma KM890 capable of producing the monoclonal antibody KM890. The monoclonal antibodies of this invention which are specifically reactive with DCC gene products can be used in immunohistochemical staining, quantitative determination of DCC gene products and the like, as well as in cancer diagnosis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4-167101 | 1992-06-25 | ||
JP16710192A JP3151054B2 (en) | 1992-06-25 | 1992-06-25 | Anti-DCC gene product monoclonal antibody |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4152193A true AU4152193A (en) | 1994-01-06 |
AU675067B2 AU675067B2 (en) | 1997-01-23 |
Family
ID=15843450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU41521/93A Ceased AU675067B2 (en) | 1992-06-25 | 1993-06-25 | Anti-DCC gene product specific monoclonal antibody |
Country Status (7)
Country | Link |
---|---|
US (1) | US5445938A (en) |
EP (1) | EP0577028B1 (en) |
JP (1) | JP3151054B2 (en) |
AT (1) | ATE201881T1 (en) |
AU (1) | AU675067B2 (en) |
CA (1) | CA2099628A1 (en) |
DE (1) | DE69330297T2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991009964A1 (en) * | 1990-01-04 | 1991-07-11 | The Johns Hopkins University | Gene deleted in colorectal cancer of humans |
WO1994028161A1 (en) * | 1993-05-26 | 1994-12-08 | The Johns Hopkins University | Antibodies specific for dcc gene product |
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US7935675B1 (en) * | 1994-07-15 | 2011-05-03 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ207394A (en) * | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
JPH03505675A (en) * | 1988-10-31 | 1991-12-12 | ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア | Producers and methods for controlling suppression of neoplastic phenotypes |
CA2065874C (en) * | 1989-09-15 | 2001-12-11 | Joseph P. Brown | Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
WO1991009964A1 (en) * | 1990-01-04 | 1991-07-11 | The Johns Hopkins University | Gene deleted in colorectal cancer of humans |
-
1992
- 1992-06-25 JP JP16710192A patent/JP3151054B2/en not_active Expired - Fee Related
-
1993
- 1993-06-24 US US08/080,809 patent/US5445938A/en not_active Expired - Fee Related
- 1993-06-24 CA CA002099628A patent/CA2099628A1/en not_active Abandoned
- 1993-06-25 EP EP93110213A patent/EP0577028B1/en not_active Expired - Lifetime
- 1993-06-25 AT AT93110213T patent/ATE201881T1/en active
- 1993-06-25 DE DE69330297T patent/DE69330297T2/en not_active Expired - Fee Related
- 1993-06-25 AU AU41521/93A patent/AU675067B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0577028A2 (en) | 1994-01-05 |
JPH067192A (en) | 1994-01-18 |
JP3151054B2 (en) | 2001-04-03 |
CA2099628A1 (en) | 1993-12-26 |
EP0577028A3 (en) | 1994-11-02 |
AU675067B2 (en) | 1997-01-23 |
DE69330297T2 (en) | 2002-05-02 |
EP0577028B1 (en) | 2001-06-06 |
US5445938A (en) | 1995-08-29 |
ATE201881T1 (en) | 2001-06-15 |
DE69330297D1 (en) | 2001-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2682296C (en) | Anti-epcam antibody and uses thereof | |
MX9504802A (en) | Anti-egfr single-chain fvs and anti-egfr antibodies. | |
AU6069496A (en) | DNA sequences used in the production of humanized chimera antibody | |
SG96535A1 (en) | Pharmaceutical composition for the treatment or prevention of a malignant tumor | |
EP0586002A3 (en) | Monoclonal antibodies recognizing the epidermal growth factor receptor, cells and methods for their production and compositions containing them | |
CA2149120A1 (en) | Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof | |
AU3933695A (en) | Humanized antibodies to CD38 | |
MY137078A (en) | Recombinant antibodies associated to gangliosides. their use indiagnosis and treatment of tumors. | |
JPH02501190A (en) | Recombinant DNA products and methods | |
CA2105618A1 (en) | Humanized antibodies to ganglioside gm2 | |
AU4876690A (en) | An expression system for production of chimeric monoclonal antibodies | |
GB2286399A (en) | Recombinant humanized anti-cytomegalovirus antibodies | |
CA2093667A1 (en) | Mouse monoclonal antibodies and uses thereof | |
EP4261223A1 (en) | Anti-sirp? antibody and application thereof | |
CA2068222A1 (en) | Monoclonal antibodies | |
EP0784684B8 (en) | RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES | |
AU4152193A (en) | Anti-DCC gene product specific monoclonal antibody | |
AU6634596A (en) | Monoclonal antibodies against soluble tnf-alpha receptors p55 and p75 as well as against tnf-alpha and its analogues | |
KR900015756A (en) | Monoclonal antibodies | |
IL187595A (en) | Pharmaceutical composition comprising a monoclonal antitumor antibody and its manufacture | |
CA2163868A1 (en) | Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them | |
NO179328C (en) | Antibodies to retinoblastoma gene product, its use and murine hybridoma | |
EP0155172A3 (en) | Anti-human lung cancer monoclonal antibodies | |
KR930019820A (en) | Monoclonal anti-ganglioside antibodies, methods for their preparation and use as tumor therapeutics | |
Hashizume et al. | Serodiagnosis of cancer, using porcine antigens recognized by human monoclonal antibody, HB4C5 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |